Evidence map›Paper›PMID 40703442›Full record

ArticleiScience2025

A deep learning-based computer-aided diagnosis system for detecting atypical endometrial hyperplasia and endometrial cancer through hysteroscopy.

Wenwen Wang, Yuyang Cai, Zhe Guo, Aihua Zhao, Wenqing Ma, Wuliang Wang, Shixuan Wang, Xin Zhu, Xin Du, Wenfeng Shen

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wenwen WangDepartment of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yuyang CaiSchool of Computer and Information Engineering, Shanghai Polytechnic University, Shanghai, China.
Zhe GuoGraduate School of Computer Science and Engineering, The University of Aizu, Aizu-Wakamatsu, Japan.
Aihua ZhaoGraduate School of Computer Science and Engineering, The University of Aizu, Aizu-Wakamatsu, Japan.
Wenqing MaDepartment of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wuliang WangDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Shixuan WangDepartment of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xin ZhuDepartment of AI Technology Development, M&D Data Science Center, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan.
Xin DuDepartment of Gynecology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wenfeng ShenSchool of Computer and Information Engineering, Shanghai Polytechnic University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Timely diagnosis of endometrial cancer (EC) and atypical endometrial hyperplasia (AEH) is crucial, yet traditional hysteroscopy faces accuracy challenges. This study introduces ECCADx, a deep learning-based computer-aided diagnosis system utilizing contrastive learning for hysteroscopic identification of AEH and EC. This is the system to integrate contrastive learning for this specific differentiation. ECCADx leveraged contrastive learning during pre-training on diverse external medical images, extracting robust features. Trained on 49,646 images from 1,204 patients, it underwent rigorous multicenter validation on two independent test datasets (6,228 images from 190 patients). ECCADx consistently achieved high diagnostic accuracy, often surpassing experienced endoscopists. Notably, it attained 95.2% sensitivity and 91.3% specificity on the internal dataset, and 92.1% sensitivity with 100% specificity on the external dataset. ECCADx proves a reliable tool, comparable or superior to human experts, promising to reduce misdiagnosis and improve patient outcomes.

Indexed as

CancerComputer-aided diagnosis methodMachine learning

Identifiers

PMID40703442
PMCPMC12283552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.